StockData
GRI Bio, Inc. logo

GRI Bio, Inc. (GRI) stock

GRINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.35−0.05 (-3.54%)

Close on Nov 17, 2026Market cap $2.95MP/E –Yield –

GRI Bio operating margin

Operating margin is operating income as a percentage of revenue.

GRI Bio's operating margin for the twelve months ending Dec 31, 2020 was -4788.0%. For fiscal 2020 it was -4788.0%.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2020Dec 31, 2020-4788.0%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2020Mar 31, 2020-1158.0%–

More GRI Bio figures

See a number that looks wrong?